Robotics company iotaMotion has received a paediatric indication expansion for its robotic-assisted iotaSOFT cochlear implant insertion system from the US Food and Drug Administration (FDA).
ST. PAUL, Minn., Jan. 14, 2026 /PRNewswire/ -- iotaMotion, Inc., creator of iotaSOFT ®, the first and only FDA cleared robotic-assisted cochlear implant insertion system, today announced U.S. Food and ...
ST. PAUL, Minn., March 11, 2026 /PRNewswire/ -- iotaMotion, Inc., the leader in robotic-assisted insertion systems for cochlear implantation and creator of iotaSOFT®, the first and only FDA cleared ...
IOWA CITY, Iowa, Sept. 29, 2020 /PRNewswire/ -- iotaMotion, Inc., an early-stage medical technology startup, announced the successful completion of the world's first two robotics-assisted cochlear ...
NEW YORK (Reuters Health) - Findings from a study conducted in rats suggest that cochlear implants, which are used to treat severe hearing loss, can cause meningitis -- inflammation of the membrane ...
The MarketWatch News Department was not involved in the creation of this content. ST. PAUL, Minn., March 11, 2026 /PRNewswire/ -- iotaMotion, Inc., the leader in robotic-assisted insertion systems for ...
The MarketWatch News Department was not involved in the creation of this content. ST. PAUL, Minn., Jan. 14, 2026 /PRNewswire/ -- iotaMotion, Inc., creator of iotaSOFT(R) , the first and only FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results